期刊文献+

髓过氧化物酶-463G/A基因多态性与冠状动脉狭窄程度相关性研究 被引量:3

下载PDF
导出
摘要 目的:探讨髓过氧化物酶-463G/A基因多态性与冠状动脉狭窄程度相关性。方法:192例经冠状动脉造影证实冠状动脉狭窄阳性患者分轻度病变组、中度病变组和重度病变组,96例阴性者设为对照组;用聚合酶链式反应-限制性片段长度多态性(PCR-RFLP)的方法测定各组基因型,并进行统计学分析。结果:对照组与冠脉狭窄各病变组基因分型差异有统计学意义(P<0.05);含A等位基因或AA等位基因的纯合子在对照组明显高于冠脉病变组(P<0.05)。结论:髓过氧化物酶MPO-463G/A基因多态性与冠脉狭窄的发生具有相关性,A等位基因可能对冠状动脉硬化的进展有保护作用。
出处 《实用医学杂志》 CAS 北大核心 2010年第21期3916-3917,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献4

二级参考文献28

  • 1[1]Piedrafita FJ,Molander RB,Vansant G,et al.An Alu element in the myeoloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element[J].J Biol Chem,1996,271(24):14 412-14 420.
  • 2[2]Brennan ML,Pennms MS,VanLente F,et al.Prognostic value of myeloperoxidase in patients with chest pain[J].N Engl J Med,2003,349(17):1 595-1 604.
  • 3[3]London SJ,Lehman TA,Taylor JA.Myeloperoxidase genetic polymorphism and lung cancer risk[J].Cancer Res,1997,57(22):5 001-5 003.
  • 4[4]Reynolds WF,Rhees J,Maciejewski D,et al.Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease[J].Exp Neurol,1999,155(1):31-41.
  • 5[5]Foster CB,Lehrnbecher T,Mol F,et al.Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease[J].J Clin Invest,1998,102(12):2 146-2 155.
  • 6[6]Carr AC,McCall MR,Frei B.Oxidation of LDL by myeloperoxidase and reactive nitrogen species[J].Arterioscler Thromb Vasc Biol,2000,20(7):1 716-1 723.
  • 7[7]Zheng L,Nukuna B,Brennan ML,et al.Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease[J].J Clin Invest,2004,114(4):529-541.
  • 8[8]Bergt C,Pennathur S,Fu X,et al.The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport[J].Proc Natl Acad Sci USA,2004,101(35):13 032-13 037.
  • 9[9]Sugiyama S,Kugiyama K,Aikawa M,et al.Hypochlorous acid,a macrophage product,induces endothelial apoptosis and tissue factor expression:Involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis[J].Arterioscler Thromb Vasc Biol,2004,24(7):1 309-1 314.
  • 10[10]Nikpoor B,Turecki G,Fournier C,et al.A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians[J].Am Heart J,2001,142(2):336-339.

共引文献14

同被引文献60

  • 1李惠,包宗明.髓过氧化物酶-463G/A基因多态性与冠心病的易患关系[J].蚌埠医学院学报,2007,32(6):657-659. 被引量:7
  • 2朱方艳,张娟,尹立红,浦跃朴.MPO和NAT2基因多态性与成人急性白血病易感性[J].中国公共卫生,2006,22(5):584-586. 被引量:12
  • 3张体艳,洪锡田,吴拥军,吴逸明.河南汉族肺癌患者髓过氧化物酶基因多态性分析[J].郑州大学学报(医学版),2007,42(3):448-450. 被引量:1
  • 4韩莉莉,沈晓丽.髓过氧化物酶及其基因多态性的研究进展[J].医学综述,2007,13(17):1288-1290. 被引量:11
  • 5Mini(n)o AM. Death in the United States,2009[J].NCHS Data Brief,2011,(64):1-8.
  • 6Yusuf S,Reddy S,Ounpuu S. Global burden of cardiovascular diseases:part Ⅰ:general considerations,the epidemiologic transition,risk factors,and impact of urbanization[J].Circulation,2001,(22):2746-2753.
  • 7Karakas M,Koenig W,Zierer A. Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors:results from the MONICA/KORA Augsburg study[J].JOURNAL OF INTERNAL MEDICINE,2012,(01):43-50.
  • 8Kathiresan S,Srivastava D. Genetics of human cardiovascular disease[J].CELL,2012,(06):1242-1257.
  • 9Tavakoli S,Asmis R. Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis[J].Antioxidants & Redox Signaling,2012,(12):1785-1795.
  • 10Soccio M,Toniato E,Evangelista V. Oxidative stress and cardiovascular risk:the role of vascular NAD(P)H oxidase and its genetic variants[J].European Journal of Clinical Investigation,2005,(05):305-314.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部